![Max Dawson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Max Dawson
Direttore operativo presso DermBiont, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Karl Beutner | M | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 7 anni |
Nichola Eliovits | M | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 7 anni |
Robert Brucker | M | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 7 anni |
Daniel Geffken | M | 67 |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 4 anni |
Steven Basta | M | 59 |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 4 anni |
Wilder Ramsey | M | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | - |
Yamen Al-Hajjar | M | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | 7 anni |
Jennifer Lee | F | - |
DermBiont, Inc.
![]() DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 8 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Max Dawson
- Contatti personali